Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
Go back to Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel| (NASDAQ: VRCA) | Delayed: 5.29 -0.15 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.44 | 52 Week High | $ | |||
| Open | $5.47 | 52 Week Low | $ | |||
| Day High | $5.47 | P/E | N/A | |||
| Day Low | $5.25 | EPS | $ | |||
| Volume | 7,397 | |||||
